• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Further evidence that Zika virus disease associated with brain and eye birth defects

byThomas SuandDeepti Shroff
August 8, 2020
in Infectious Disease, Neurology, Obstetrics, Ophthalmology, Pediatrics, Public Health
Reading Time: 3 mins read
Nanoparticle delivery of aurora kinase inhibitor may improve tumor treatment [PreClinical]
Share on FacebookShare on Twitter

1. The prevalence of brain and eye defects was elevated during the 2015-2016 Zika virus outbreak in Colombia compared to the periods immediately before and after the outbreak.

2. Pregnant women who began displaying symptoms of Zika virus disease in the first trimester were significantly more likely to have a preterm birth or pregnancy loss compared to those who had later symptom onset.

Evidence Rating Level: 2 (Good)

Study Rundown: In 2015, an outbreak of the Zika virus began in Brazil and quickly swept through the Americas. Colombia was among the countries most affected by the epidemic, with more than 100,000 individuals displaying symptoms of Zika virus disease (ZVD) in less than one year’s time. Further, a study conducted in 2016 revealed that the frequency of microcephaly in the nation had quadrupled since the previous year, consistent with other studies that suggested an association between antenatal exposure to Zika virus and various neurodevelopmental abnormalities. Given the relatively mild severity of the disease in the overall population, it was likely that a significant number of cases went unreported; thus, the extent to which this increase in birth defects could be attributed to ZVD was unclear. In this study, national birth defect surveillance data and ZVD surveillance data were analyzed in order to evaluate the occurrence of brain and eye defects in several groups and subgroups of pregnant women: those belonging to the general population, those with ZVD symptoms, and those with laboratory-confirmed ZVD. It was found that, among those with laboratory-confirmed ZVD, 2% of their infants had a brain or eye defect; those who had an onset of symptoms during the first trimester were roughly 3 times more likely to have a newborn with a brain or eye defect and roughly 4 times more likely to have pregnancy loss compared to those whose onset occurred in the second or third trimesters. Additionally, the overall prevalence of brain or eye defects was significantly higher in the peri-epidemic period compared to the periods immediately before and after.

Click here to read the study, published in NEJM

Relevant Reading: Zika Virus Infection in Pregnant Women in Rio de Janeiro

RELATED REPORTS

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

Maternal smoking is associated with increased risk of sudden unexpected infant death

2 Minute Medicine Rewind March 23, 2026

In-Depth [retrospective cohort]: Between June 2015 and July 2016, 18,117 pregnant women reported having clinical symptoms of ZVD. Of these women, 5673 had positive serum samples on real-time reverse-transcriptase polymerase chain reaction assays and reported both gestational age at the time of symptom onset and pregnancy outcome. Adverse outcomes were observed in 790 (14%) of these pregnancies, with 93 (2%) being brain or eye defects. The pregnancies of women who had symptom onset in the first trimester accounted for 40 (43%) of these defects despite the subgroup comprising only 1192 individuals (21%). These women were also more likely to have pregnancy loss (8% vs. 2%) or a preterm birth (10% vs. 7%) compared to those with a later symptom onset. Analyzing all pregnancies in Colombia regardless of ZVD status, 1451 infants were born with a brain or eye defect between September 2015 and April 2017. This corresponded to a nationwide prevalence of 13 cases (95% CI, 13-14) per 10,000 live births, with regional prevalences ranging from 5 to 81 per 10,000 live births. In comparison, the overall prevalences in 2014 and 2018 were 8 (95% CI, 7-9) per 10,000 live births and 11 (95% CI, 10-12) per 10,000 live births, respectively.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: microcephalyneurodevelopmental disorderspregnancyZika virus disease (ZVD)
Previous Post

#VisualAbstract: Roflumilast for chronic plaque psoriasis associated with clearer skin

Next Post

Postexposure prophylactic use of hydroxychloroquine not effective for Covid-19 prevention

RelatedReports

Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

May 6, 2026
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Obstetrics

Maternal smoking is associated with increased risk of sudden unexpected infant death

April 9, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Functional recovery after maternal ischemic stroke may be commonly favourable

January 26, 2026
Next Post
Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces

Postexposure prophylactic use of hydroxychloroquine not effective for Covid-19 prevention

#VisualAbstract: Roflumilast for chronic plaque psoriasis associated with clearer skin

#VisualAbstract: Clinical validity of SARS-CoV-2 antibodies

No survival benefit with ICDs in non-ischemic systolic heart failure: The DANISH trial

Subcutaneous ICDs noninferior to transvenous ICDs for device related complications

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
  • Few interventions improve posthospitalization follow-up for alcohol use disorder
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.